Tick Borne Encephalitis Global Clinical Trials Review, H2, 2016
SKU ID :GD-10264961 | Published Date: 27-Jul-2016 | No. of pages: 50Description
TOC
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Europe 8
Top Countries Contributing to Clinical Trials in North America 9
Clinical Trials by G7 Countries: Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials 10
Clinical Trials by Phase in G7 Countries 11
Clinical Trials in G7 Countries by Trial Status 12
Clinical Trials by E7 Countries: Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Subjects Recruited Over a Period of Time 18
Clinical Trials by Sponsor Type 19
Prominent Sponsors 20
Top Companies Participating in Tick Borne Encephalitis Therapeutics Clinical Trials 21
Prominent Drugs 22
Clinical Trial Profile Snapshots 23
Appendix 47
Abbreviations 47
Definitions 47
Research Methodology 48
Secondary Research 48
About GlobalData 49
Contact Us 49
Disclaimer 49
Source 50
Tables & Figures
List of Tables
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Region, 2016* 5
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Tick Borne Encephalitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 8
Tick Borne Encephalitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 9
Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 10
Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 11
Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 12
Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 13
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Phase, 2016* 14
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 15
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 17
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 18
Tick Borne Encephalitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 19
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 21
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 22
List of Figures
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Tick Borne Encephalitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 8
Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, G7 Countries (%), 2016* 10
Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 11
Tick Borne Encephalitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 12
Proportion of Tick Borne Encephalitis to Central Nervous System Clinical Trials, E7 Countries (%), 2016* 13
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 14
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 15
Tick Borne Encephalitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 17
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 18
Tick Borne Encephalitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 19
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 21
Tick Borne Encephalitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 22
GlobalData Methodology 48
Companies
Pfizer Inc.
Baxter International Inc.
Microgen Scientific Industrial Company for Immunobiological Medicines
Novartis AG
SGS North America, Inc.
Monipol sp. z o.o.
BIOVOMED
- PRICE
-
$2500$7500